SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 119 filers reported holding SUTRO BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $631,544 | -59.8% | 135,816 | -60.1% | 0.00% | -50.0% |
| Q1 2023 | $1,572,703 | -18.2% | 340,412 | +43.1% | 0.00% | -33.3% |
| Q4 2022 | $1,922,192 | +95.5% | 237,895 | +34.3% | 0.01% | +100.0% |
| Q3 2022 | $983,000 | +3.1% | 177,089 | -3.2% | 0.00% | 0.0% |
| Q2 2022 | $953,000 | -28.8% | 182,896 | +12.3% | 0.00% | -25.0% |
| Q1 2022 | $1,339,000 | -20.4% | 162,912 | +44.1% | 0.00% | 0.0% |
| Q4 2021 | $1,683,000 | -60.8% | 113,083 | -50.3% | 0.00% | -60.0% |
| Q3 2021 | $4,297,000 | +13.3% | 227,481 | +11.5% | 0.01% | +11.1% |
| Q2 2021 | $3,793,000 | +40.6% | 204,044 | +72.2% | 0.01% | +28.6% |
| Q1 2021 | $2,697,000 | +154.2% | 118,510 | +142.6% | 0.01% | +133.3% |
| Q4 2020 | $1,061,000 | -2.0% | 48,852 | -54.7% | 0.00% | -25.0% |
| Q3 2020 | $1,083,000 | – | 107,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |